Results 61 to 70 of about 19,674,936 (195)

Rome Iv Diagnostic Criteria For Functional Gastrointestinal Disorders in Egyptian Patients With Chronic HCV [PDF]

open access: yesMinia Journal of Medical Research, 2019
Introduction: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide 2017.
Hoda Hassan   +2 more
doaj   +1 more source

Influence of IL-10RA and IL-22 polymorphisms on outcome of hepatitis C virus infection.

open access: yes, 2007
BACKGROUND: Two receptor chains, IL-10RA and IL-10RB, are known to mediate the functions of interleukin-10 (IL-10), which has been shown to be involved in the progression of persistent hepatitis C virus (HCV) infection. Little information is available on
Thursz, Mark   +20 more
core   +1 more source

Human immunodeficiency virus : 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus [PDF]

open access: yes, 2009
The human immunodeficiency virus (HIV) had spread unrecognized in the human population as sexually transmitted disease and was finally identified by its disease AIDS in 1981.
Hans Wilhelm Doerr   +5 more
core   +1 more source

SEROCONVERSION RATE OF HEPATITIS C VIRUS INFECTION AMONG HAEMODIALYSIS PATIENTS IN AL-KADHIMIYA TEACHING HOSPITAL (DIALYSIS UNIT)

open access: yesThe Iraqi Journal of Medical Sciences, 2016
Background:Hepatitis C virus (HCV) infection is a serious public health problem throughout the world. Chronic haemodialysis patients are at higher risk for acquiring hepatitis C virus (HCV) infection.
Hasanain MH AL-Rubaie, Arif S Malik
doaj   +4 more sources

Hepatitis C virus (HCV) infection in Africa: a review

open access: yesPan African Medical Journal, 2013
Hepatitis C virus (HCV) is a viral pandemic and a leading cause of chronic liver disease. This review highlights the epidemiology and management of Hepatitis C in Africa. We searched for articles on medline using the terms, "Hepatitis C", "Prevalence", "Epidemiology", "Africa" and "Treatment".
Karoney, Mercy Jelagat   +1 more
openaire   +4 more sources

Dendritic cell function in the setting of chronic hepatitis c infection and changes during antiviral treatment [PDF]

open access: yes, 2009
The role of the innate immune system and in particular of dendritic cells, in the establishment of chronic hepatitis C has been studied quite extensively over the last few years but controversy remains as to whether a potential virus-induced defect in
Pachiadakis, I.
core  

HCV treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals. [PDF]

open access: yes, 2013
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is
Dillon, John   +40 more
core   +1 more source

Targets for Hepatitis C virus test uptake and case-finding among injecting drug users : in prisons and general practice [PDF]

open access: yes, 2010
We re-analyse data on new diagnoses of Hepatitis C virus (HCV) for injectors in prison or attending general practices which were relied on for the cost-effectiveness of HCV testing in injectors.
Robertson, Roy   +3 more
core   +4 more sources

Servo prevalence of hepatitis B and C and HIV in multiple transfusions ß-thalassemia: Result from an only thalassemia day care unit in Kerman-Iran

open access: yesMediterranean Journal of Hematology and Infectious Diseases, 2014
Patients with major ß-thalassemia require multi-transfusions for survival. They are at a high risk for blood transfusion transmitted infections, particularly with Hepatitis B virus (HBV), Hepatitis C virus (HCV) and Human immunodeficiency virus (HIV ...
Amir-Hooshang Sheikh-Bardsiri   +3 more
doaj  

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic Hepatitis C virus infection in a European cohort: A cross-sectional study [PDF]

open access: yes, 2011
Background To date, drug response genes have not proved as useful in clinical practice as was anticipated at the start of the genomic era. An exception is in the treatment of chronic hepatitis C virus (HCV) genotype 1 infection with pegylated interferon-
Hellard, M   +159 more
core   +1 more source

Home - About - Disclaimer - Privacy